These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33429293)

  • 1. Selective serotonin reuptake inhibitors use and hepatocellular carcinoma in patients with alcohol use disorder.
    Chen VC; Lee MJ; Yang YH; Lu ML; Chiu WC; Dewey ME
    Drug Alcohol Depend; 2021 Feb; 219():108495. PubMed ID: 33429293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis C?
    Pocha C; Knott A; Rector TS; Dieperink E
    J Clin Psychiatry; 2014 Oct; 75(10):e1122-6. PubMed ID: 25373121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients.
    Chang CM; Hsieh MS; Yang TC; Hsieh VC; Chiang JH; Huang HH; How CK; Hu SY; Yen DH
    Cancer Manag Res; 2017; 9():709-720. PubMed ID: 29238221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants.
    Bhagavathula AS; Woolf B; Rahmani J; Vidyasagar K; Tesfaye W
    Eur J Clin Pharmacol; 2022 Apr; 78(4):547-555. PubMed ID: 35039907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRIs associated with decreased risk of hepatocellular carcinoma: A population-based case-control study.
    Chan HL; Chiu WC; Chen VC; Huang KY; Wang TN; Lee Y; McIntyre RS; Hsu TC; Lee CT; Tzang BS
    Psychooncology; 2018 Jan; 27(1):187-192. PubMed ID: 28666060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study.
    Lin WT; Liao YJ; Peng YC; Chang CH; Lin CH; Yeh HZ; Chang CS
    World J Gastroenterol; 2017 May; 23(19):3513-3521. PubMed ID: 28596687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder.
    Chiu WC; Shan JC; Yang YH; Chen VC; Chen PC
    Drug Alcohol Depend; 2021 Nov; 228():109096. PubMed ID: 34600254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant use and hepatocellular carcinoma in patients with hepatitis C who had received interferon therapy: A population-based cohort study.
    Chen VC; Lu ML; Yang YH; Weng JC; Chang CC
    J Affect Disord; 2019 Jun; 253():147-153. PubMed ID: 31035215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.
    Sun JW; Hernández-Díaz S; Haneuse S; Bourgeois FT; Vine SM; Olfson M; Bateman BT; Huybrechts KF
    JAMA Psychiatry; 2021 Jan; 78(1):91-100. PubMed ID: 32876659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between selective serotonin reuptake inhibitors and kidney cancer risk: A nationwide population-based cohort study.
    Lee MJ; Huang CW; Chen YL; Yang YH; Chen VC
    Int J Cancer; 2021 Mar; 148(6):1331-1337. PubMed ID: 32965039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Serotonin Reuptake Inhibitors and Poststroke Epilepsy: A Population-Based Nationwide Study.
    Chou CC; Yen DJ; Lin YY; Wang YC; Lin CL; Kao CH
    Mayo Clin Proc; 2017 Feb; 92(2):193-199. PubMed ID: 28160872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.
    Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
    Breast Cancer Res; 2018 Jan; 20(1):4. PubMed ID: 29351761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of hospitalization for upper gastrointestinal bleeding in users of selective serotonin reuptake inhibitors after Helicobacter pylori eradication therapy: a propensity score matching analysis.
    Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2019 Nov; 50(9):1001-1008. PubMed ID: 31583734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
    Kwak N; Lee H; Kim BK; Yu YM; Kang HY
    J Gastroenterol Hepatol; 2024 Feb; 39(2):280-288. PubMed ID: 37961007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between selective serotonin reuptake inhibitor and risk of peripheral artery disease in diabetes mellitus: Propensity score matching and landmark analysis.
    Chen KH; Wang TY; Lee CP; Yang YH; McIntyre RS; Subramaniapillai M; Lee Y; Chen VC
    Medicine (Baltimore); 2022 May; 101(18):e29202. PubMed ID: 35550469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
    Lin YT; Lu TS; Hansen RA; Wang CC
    Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding: A Nationwide Population-Based Cohort Study in Taiwan.
    Cheng YL; Hu HY; Lin XH; Luo JC; Peng YL; Hou MC; Lin HC; Lee FY
    Medicine (Baltimore); 2015 Nov; 94(46):e2022. PubMed ID: 26579809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors.
    Desai R; Smith SM; Mohandas R; Brown J; Park H
    Ann Pharmacother; 2024 Sep; 58(9):886-895. PubMed ID: 38078408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors and risk of epilepsy after traumatic brain injury - A population based cohort study.
    Christensen J; Pedersen HS; Fenger-Grøn M; Fann JR; Jones NC; Vestergaard M
    PLoS One; 2019; 14(7):e0219137. PubMed ID: 31323024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C.
    Kao WY; Su CW; Chia-Hui Tan E; Lee PC; Chen PH; Tang JH; Huang YH; Huo TI; Chang CC; Hou MC; Lin HC; Wu JC
    Hepatology; 2019 Mar; 69(3):1151-1164. PubMed ID: 30175498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.